Avenue Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$0
$0
EBITDA
-2,823
-3,708
-2,119
-2,068
EBIT
-5,646
-7,416
-4,238
-4,136
Net Income
-7,186
-4,340
640
526
Net Change In Cash
0
0
0
0
Free Cash Flow
-2,253
-3,120
676
-1,889
Cash
4,919
3,194
1,783
161
Basic Shares
1,117
562
25,597
8,114

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
EBITDA
4,163
-8,023
-3,731
-5,213
EBIT
-10,377
-16,066
-3,738
-5,213
Net Income
-10,377
2,048
-3,724
-5,089
Net Change In Cash
0
0
0
0
Cost of Revenue
-5,613
Free Cash Flow
-12,451
-7,596
-3,750
-5,613
Cash
1,783
6,708
3,763
3,132
Basic Shares
141
2,185
1,133
1,100

Earnings Calls

Quarter EPS
2024-06-30
-$6.43
2024-03-31
-$15.40
2023-12-31
$0.06
2023-09-30
$0.06